Nigericin is a potent inhibitor of the early stage of vaccinia virus replication. (Record no. 20255009)

MARC details
000 -LEADER
fixed length control field 01538 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516005046.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201102s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1872-9096
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.antiviral.2010.10.001
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Myskiw, Chad
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20110228
245 00 - TITLE STATEMENT
Title Nigericin is a potent inhibitor of the early stage of vaccinia virus replication.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Antiviral research
Date of publication, distribution, etc. Dec 2010
300 ## - PHYSICAL DESCRIPTION
Extent 304-10 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bioterrorism
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carboxylic Acids
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gene Expression Regulation, Viral
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Green Fluorescent Proteins
General subdivision analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HeLa Cells
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Inhibitory Concentration 50
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nigericin
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Poxviridae Infections
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Transcription, Genetic
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vaccinia virus
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Virus Replication
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Piper, Jessica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huzarewich, Rhiannon
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Booth, Tim F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cao, Jingxin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name He, Runtao
773 0# - HOST ITEM ENTRY
Title Antiviral research
Related parts vol. 88
-- no. 3
-- p. 304-10
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.antiviral.2010.10.001">https://doi.org/10.1016/j.antiviral.2010.10.001</a>
Public note Available from publisher's website

No items available.